Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Easton Pharmaceuticals is a specialty pharmaceutical company that designs, develops, and markets a diverse array of topically delivered drugs and health products. The company's core portfolio focuses on therapeutic areas such as women's health, wound care, and oncology, featuring products like Viorra for female sexual dysfunction and Nauseasol for motion sickness. Beyond traditional pharmaceuticals, Easton has expanded its interests into the medical cannabis sector and regenerative medicine through partnerships involving amniotic fluid-derived treatments. The firm typically utilizes a business model centered on acquiring or licensing proprietary technologies and sub-licensing them to international partners for global distribution. Headquartered in Toronto, Easton Pharmaceuticals trades publicly on the OTC markets under the symbol EAPH.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Easton Pharma.